Prenatal and postnatal exposure to PFAS and cardiometabolic factors and inflammation status in children from six European cohorts

Autor: John Wright, Oliver Robinson, Anne Lise Brantsæter, L. Chatzi, Eleni Papadopoulou, Rosemary R. C. McEachan, Léa Maitre, Rémy Slama, Barbara Heude, Regina Gražulevičienė, Maribel Casas, Xavier Basagaña, Line Småstuen Haug, Marina Vafeiadi, Eduard Sabidó, Martine Vrijheid, Serena Fossati, Jose Urquiza, Yinqi Zhao, Nikos Stratakis, David V. Conti, Eva Borràs, Theano Roumeliotaki
Přispěvatelé: Medical Research Council (MRC), RS: CAPHRI - R5 - Optimising Patient Care, Complexe Genetica
Jazyk: angličtina
Rok vydání: 2021
Předmět:
Infants -- Malalties
BKMR
PFAS
CHILDHOOD
Physiology
010501 environmental sciences
01 natural sciences
SERUM
chemistry.chemical_compound
0302 clinical medicine
Pregnancy
Cor--Malalties
Medicine
GE1-350
030212 general & internal medicine
General Environmental Science
METABOLIC SYNDROME
Adiposity
Fluorocarbons
ASSOCIATION
3. Good health
Alkanesulfonic Acids
Cardiovascular Diseases
Environmental Pollutants
Female
medicine.symptom
Exposome
YOUNG-CHILDREN
Waist
HDL
Inflammation
PERFLUOROALKYL SUBSTANCES
PROFILE
PERFLUORINATED CHEMICALS
03 medical and health sciences
Endocrine system
Humans
0105 earth and related environmental sciences
business.industry
Cholesterol
NORWEGIAN MOTHER
Bayes Theorem
medicine.disease
Cardiometabolic risk
chemistry
Metabolic syndrome
PERFLUOROOCTANOIC ACID
business
Environmental Sciences
Lipoprotein
Zdroj: Environment International, Vol 157, Iss, Pp 106853-(2021)
Environment International, 157:106853. Elsevier Science
Environment International
ISSN: 0160-4120
Popis: Developing children are particularly vulnerable to the effects of exposure to per- and polyfluoroalkyl substances (PFAS), a group of endocrine disrupting chemicals. We hypothesized that early life exposure to PFASs is associated with poor metabolic health in children. We studied the association between prenatal and postnatal PFASs mixture exposure and cardiometabolic health in children, and the role of inflammatory proteins. In 1,101 mothers-child pairs from the Human Early Life Exposome project, we measured the concentrations of PFAS in blood collected in pregnancy and at 8 years (range = 6-12 years). We applied Bayesian Kernel Machine regression (BKMR) to estimate the associations between exposure to PFAS mixture and the cardiometabolic factors as age and sex- specific z-scores of waist circumference (WC), systolic and diastolic blood pressures (BP), and concentrations of triglycerides (TG), high-density lipoprotein (HDL-C) and low-density lipoprotein (LDL-C) cholesterol. We measured thirty six inflammatory biomarkers in child plasma and examined the underlying role of inflammatory status for the exposure-outcome association by integrating the three panels into a network. Exposure to the PFAS mixture was positively associated with HDL-C and systolic BP, and negatively associated with WC, LDL-C and TG. When we examined the independent effects of the individual chemicals in the mixture, prenatal PFHxS was negatively associated with HDL-C and prenatal PFNA was positively associated with WC and these were opposing directions from the overall mixture. Further, the network consisted of five distinct communities connected with positive and negative correlations. The selected inflammatory biomarkers were positively, while the postnatal PFAS were negatively related with the included cardiometabolic factors, and only prenatal PFOA was positively related with the pro-inflammatory cytokine IL-1beta and WC. Our study supports that prenatal, rather than postnatal, PFAS exposure might contribute to an unfavorable lipidemic profile and adiposity in childhood. This work was supported by the Norwegian Research Council under the MILJØFORSK-Miljøforskning for en grønn samfunnsomstilling call (project No. 268465-short name: "CATCHUP project"). The HELIX project is funded by the European Community's Seventh Framework Programme (FP7/2007–2013) under grant agreement no 308,333 – the HELIX project. The HELIX program is built on six existing cohorts that received previous funding. The Born in Bradford (BiB) study presents independent research commissioned by the National Institute for Health Research Collaboration for Applied Health Research and Care (NIHR CLAHRC) and the Programme Grants for Applied Research funding scheme (RP-PG-0407–10044). INMA data collections were supported by grants from the Instituto de Salud Carlos III, CIBERESP, and the Generalitat de Catalunya-CIRIT. KANC was funded by the grant of the Lithuanian Agency for Science Innovation and Technology (6–04-2014_31V-66). Dr. Maribel Casas received funding from Instituto de Salud Carlos III (Ministry of Economy and Competitiveness) (MS16/00128). Dr. Leda Chatzi was supported by NIH/NIHES R01 ES029944, R01ES030691, R01ES030364, R21 ES029681, R21 ES028903, and P30 ES007048-23. Dr. David Conti was supported by P01CA196569, R01CA140561, R01 ES016813, R01 ES029944, R01ES030691, R01ES030364. Dr. Nikos Stratakis was supported by NIH/NIHES R21 ES029681 and P30 ES007048-23, and NIH/NIDDK P30 DK048522-24. The CRG/UPF Proteomics Unit is part of the Spanish Infrastructure for Omics Technologies (ICTS OmicsTech) and it is a member of the ProteoRed PRB3 consortium which is supported by grant PT17/0019 of the PE I + D + i 2013–2016 from the Instituto de Salud Carlos III (ISCIII) and ERDF. ISGlobal affiliated researchers acknowledge support from the Spanish Ministry of Science, Innovation and Universities, “Centro de Excelencia Severo Ochoa 2013–2017”, SEV-2012–0208, and “Secretaria d’Universitats i Recerca del Departament d’Economia i Coneixement de la Generalitat de Catalunya” (2017SGR595)
Databáze: OpenAIRE
Externí odkaz: